Effective Strategy 2021 - Developing an Effective Strategy for Testing Raw Materials in Phase 1 Through Phase 3 Environment

Risk management of raw materials in a GMP environment is an area that is often overlooked as a Company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products
This live training webinar will also examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2 and 3. It will cover testing requirements during each Phase and what may be optional until the product moves to its next Phase.
How to develop an overall strategy for testing raw materials in Phase 1 through Phase 3 environment.
What raw material testing is required during various Phases of clinical trials.
What your Certificate of Analysis may tell you.
Speaker:
Barry A. Friedman, Ph.D., is a Senior Consultant in the Biotechnology, Regulatory Compliance and Aseptic Processing arena. From 2000 to 2007,